has been synthesised and evaluated in cellulo, based on established bicyclic NMDA receptor antagonists. Their use as responsive MR imaging probes has been evaluated in suspensions of NSC-34 cells, and one agent exhibited significant enhancements in measured longitudinal and transverse water proton relaxation rates (19 and 38% respectively; 3T, 298K). A biotin derivative of the lead compound was prepared and the specificity and reversibility of binding to the NMDA cell surface receptors demonstrated using confocal laser scanning microscopy.
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Introduction
Receptors for N-methyl-D-aspartate (NMDA) are found on the surface of neurons (e.g. astrocytes) and constitute part of the ligand-gated ionotropic family of glutamate receptor proteins.
1 These receptors play a key role in excitatory neurotransmission and in memory and learning. Many central nervous system (CNS) disorders have been related to the misregulation or over-stimulation of NMDA receptors including epilepsy, ischemia, Parkinson's and Alzheimer's diseases. [2] [3] [4] Selective antagonists of the NMDA receptors (NMDAR) have also been studied, exploring their potential as imaging or therapeutic agents for these and related CNS disorders. 5, 6 OBC 2014 2
One of the goals of molecular imaging is to provide more detailed spatiotemporal information on the chemical processes occurring in the brain that are associated with neurotransmission and its relationship to learning, cognitive behaviour and disease status and progression. The utility of MRI is improved by the use of contrast agents, especially those that enhance specificity and sensitivity by targeting certain regions of interest, or that allow the monitoring of changes in chemical composition as a function of neural activity. This rationale has driven the recent development of contrast agents that selectively target the various glutamate receptors that are found on the cell surface of astrocytes in high abundance. 7, 8, 9 Such responsive contrast agents must be able to bind selectively and reversibly to the receptor, so that changes in local contrast agent levels can be modulated following the glutamate bursts that periodically occur following a stimulus. Given that release of glutamate from a presynaptic cell takes place over a period of milliseconds and should displace the contrast agent from the cell surface receptor, MRI may be able to monitor the restoration to equilibrium that occurs over a period of a second or two. 10 As the glutamate levels drop and the contrast agent competes in binding to the receptor, glutamate is displaced, leading to local signal intensity enhancement once more. Such a perturbational approach requires that the contrast agents bind reversibly and with relatively high affinity to the target site, with minimal non-specific binding.
For these reasons, we have set out to examine conjugates of gadolinium contrast agents with established competitive antagonists for glutamate receptors. When bound to the receptor site, the local rotational dynamics and second sphere of hydration around the gadolinium moiety are perturbed leading to relaxivity enhancement and increased contrast. In our initial work with NMDA receptor targeted gadolinium conjugates, we reported the synthesis and behaviour of competitive NMDAR antagonists based on a 3,4-diamino-3-cyclobutene-1,2-dione developed by Kinney. 11a The NMDA receptor is a tetrameric complex, most commonly built up from alternating GluN1 and GluN2 subunits. Based on the work of Kinney 11b , these receptor binding moieties are a class of competitive antagonists. Therefore, they must bind at the GluN2 subunit where the glutamate binding site is located. However, the GluN2 subunit can be one of four genetic products (GluN2A-D) and the relative expression levels of each can vary between each receptor. In initial work 13 , immunofluorescence staining experiments were undertaken to establish the presence of the GluN2B subunit.
The targeting moieties based on the competitive antagonist moiety were conjugated to a modified Gd-DOTA complex that possesses a single fast-exchanging water molecule, e.g.
[Gd.L a-d ], Scheme 1. When water exchange at the Gd centre is fast (typically of the order of 10 7 s -1 at 298 K), then the relaxivity, (the increment of the water proton relaxation rate per unit complex concentration) in the low to mid-field range (1 to 3 T), is dominated by rotational dynamics and hence is more sensitive to receptor binding. 12 Initial studies in cell suspensions
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of the NSC-34 cell line showed relaxation enhancements of up to 75% on cell surface binding versus controls lacking the NMDA receptors. 13 The conjugates were non-toxic, as revealed by standard IC 50 studies using an MTT assay that assesses perturbation of mitochondrial redox status, consistent with evidence from optical microscopy studies that revealed no evidence for internalization of the conjugate. Furthermore, the confocal microscopy studies established both the specificity and the reversibility of probe binding, in the absence and presence of added glutamate.
13
Scheme 1
Here, we report the synthesis and evaluation of an additional series of complexes constituting a secondgeneration, [Gd.L 1 -L 6 ] (Scheme 1) in which the monocyclic antagonist group is replaced by a bicyclic moiety, for which receptor binding affinities were established to be about an order of magnitude higher, in the original small molecule work. 11b The nature of the spacing chain differs in each case and four examples with shorter linkages (Gd.L 1 -Gd.L 4 ) were examined together with two analogues (Gd.L 5 , Gd.L 6 ) in which the spacing chain was longer. The rationale behind this selection of targets was that the further away the targeting vector was from the paramagnetic Gd 3+ centre, the less likely that receptor binding would be compromised. However, the longer the chain the less motional coupling will occur between the gadolinium moiety and the slowly tumbling macromolecule, comparing free and receptor bound complexes and hence the smaller may be any relaxivity enhancement.
In addition, we have examined the behaviour of the biotin conjugate, [Gd.
, in which the biotin moiety allows selective tagging to fluorescently labelled avidin conjugates to allow visualization of the avidin-biotin probe conjugate using confocal microscopy.
OBC 2014 4
Results and Discussion
Synthesis of the ligands and complexes
The synthesis of the required bicyclic antagonist moieties followed methods adapted from the work of Kinney 11b . Orthogonal protection of 1,3-diamino-propan-2-ol was achieved in high yield following stepwise Boc and Z protection steps. 14a Subsequent mesylation of the free alcohol, followed by substitution with NaN 3 in DMF afforded the azide, 3 (Scheme 2). The azide group served as a 'masked' amine, which was transformed to a primary amine group in the final step of the synthesis. A reagent for selective removal of the CBz protecting group from 3 was required. This ruled out the use of standard deprotection methods, such as hydrogenation over a palladium catalyst, as this would also reduce the azide group. Instead, Ba(OH) 2 in refluxing aqueous glyme was used, and gave the free amine, 4, in good yield.
14b N-Alkylation with, for example, diethyl-(2-bromo)ethyl phosphonate in the presence of Na 2 CO 3 gave the mono-substituted amine, 7, in modest yield, which was used in a Michael addition-elimination reaction with diethoxy-3-cyclobutene-1,2-dione. The phosphonate ester 11 was obtained as a pair of rotamers in a 1:1.2 ratio as deduced by 31 P NMR spectroscopy.
Cyclisation was achieved in high yield after selective hydrolysis of the Boc protecting group, followed by heating the free amine in ethanol in the presence of a tertiary amine. By studying the 1 H NMR spectrum of the cyclised azide, 15, it was possible to deduce that the conformation adopted by this and related bicyclic intermediates involved selective population of a twist-chair isomer (ESI). In a similar manner, compounds 13, 14 and 16 were prepared.
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Scheme 2. Synthesis of the competitive antagonist moieties (adapted from reference 11b)
With the azide in hand, mild, selective reduction to unmask the primary amine functionality was accomplished using a standard Staudinger reaction, using triphenylphosphine in a Human serum albumin (HSA) constitutes around 4.5% of plasma and is the major protein constituent in the circulatory system. Each contrast agent will bind to the protein to some extent, disrupting its rotational dynamics and leading to an enhancement of the longitudinal relaxation rate of the water protons. As a control experiment, the effect of added HSA on the measured relaxivity of [Gd.L 1-6 ] (each at 1 mM) was assessed at 1.4 T following incremental addition of up to 1.6 mM HSA. Increases in r 1p were observed and association constants were estimated by assuming measuring the Gd cell uptake using ICP-MS. After a 24h incubation, followed by washing of the cells with fresh buffer three times, less than 2% Gd 3+ cell uptake was measured in each case, and the gadolinium was found in the washings (ca. 98%).
Cellular optical imaging
It was hypothesised that the observed increase in relaxation rates per cell were due to binding of the Gd probe to NMDA receptors on the cell surface. However, cell labelling of the Gd complex via non-specific binding to the cell membrane or by internalisation involving receptor-mediated endocytosis are plausible mechanisms that may lead to the observed increase in R 1,cell . To distinguish these possibilities, the biotin complex was designed to allow tracking of the contrast agent on the cell surface. Furthermore, by using the same microscope settings as used previously, 13 it was possible to demonstrate that cells treated with [Gd.L 7 ] were 38% brighter than when they were treated with the acyclic analogue, consistent with the bicyclic targeting moiety having a higher receptor affinity.
Confirmation that the observed fluorescence was due to the strong biotin-avidin interaction between [Gd. Table 2 . 2-were undertaken ( Table 2 and Fig. 2H and I) , and the observation of about 50% of the original signal in each case is consistent with each of these complexes having a similar binding affinity for the NMDA receptor site.
Competition experiments and reversibility of receptor binding
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Conclusions
A second generation of MR imaging probes has been created that target the NMDAR, Binding of the Gd contrast agents to the NMDA receptors was shown to be reversible. Melting points were recorded using a Gallenkamp (Sanyo) apparatus and are uncorrected. 
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The apparent binding constant for the interaction of the Gd 3+ complex with Human Serum Albumin (HSA) was calculated using equation (2) Details of cell experiments, microscopy, and the MTT assays used have been given in earlier papers in this series. [7] [8] [9] 13 The other compounds, ligands and Gd complexes not reported below are described in the ESI. hours, the reaction mixture was concentrated and the residue re-dissolved in brine (50 mL).
Ligand and Complex synthesis
The pH was adjusted to 5 by treatment with HCl (1 N), washed with dichloromethane (3 x 50 mL) and made basic (pH 12) by the addition of NaOH solution (2.5 M). The product was extracted using copious amounts of CHCl 3 (5 x 100 mL), dried over MgSO 4 , filtered and concentrated to yield 1 as a white solid (1.23 g, 34% 
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and the solvent removed under reduced pressure. The residue was partially dissolved in brine and the pH adjusted to 5 using HCl (1 N). The aqueous portion was washed with dichloromethane (2 x 100 mL) before adjusting the pH to 12 using NaOH solution (2.5 M).
The product was extracted with copious amounts of CHCl 3 (5 x 100 mL), dried over MgSO 4 , filtered and concentrated to give a colourless oil (257 mg, 69% 
Methyl 3-((2-azido-3-((tert-butoxycarbonyl)amino)propyl)amino)propanoate, 6
A solution of tert-butyl give the ester as a colourless oil (396 mg, 55% 
Diethyl-3-(4-azido-8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)propyl)phosphonate, 16
To a solution of tert-butyl (2-azido-3-((3-(diethoxyphosphoryl)propyl)(2-ethoxy-3,4-dioxocyclobut-1-en-1-yl)amino)propyl)carbamate (201 mg, 0.39 mmol) in anhydrous dichloromethane (1 mL) was added TFA (1 mL), and the resulting solution stirred at room temperature for 1 hour. Reaction was complete after this period, as indicated by TLC, and the solvents were removed under reduced pressure. The residue was re-dissolved in dichloromethane and again reduced under reduced pressure. This process was repeated 5 times to ensure complete removal of excess TFA. The TFA salt was dissolved in anhydrous ethanol (5 mL) to which a solution of triethylamine (218 µL, 1.56 mmol) in anhydrous ethanol (2 mL) was added over a 20 minute period. The resulting solution was heated to reflux for 18 hours, until no further reaction was observed by TLC. At this point, the solvent was removed under reduced pressure and the crude residue purified by column chromatography (DCM/MeOH, 100% to 90:10 using 1% increments; R f = 0.26) to give a colourless oil (126 mg, 87% This product was characterized as a pair of diastereoisomers (57 mg, 28% Compound 26 (10 mg, 0.007 mmol) was dissolved in DCM (1 mL) with stirring. To this solution was added trifluoroacetic acid (1 mL) and the resulting solution stirred at room temperature for overnight. Hydrolysis of the tert-butyl ester groups was verified by ESI-MS,
